Latest Industry Updates
Stay up to date with the latest industry updates from the global drug development technology industryLatest Update
Active Biotech and Ipsen have announced that 600 patients have been recruited in the global, pivotal, randomised, double-blind, placebo-controlled Phase 3 study of tasquinimod, used to...
> read more
News
Peregrine reports top-line data from bavituximab study
Peregrine Pharmaceuticals has announced positive results from its randomised, double-blind, placebo-controlled Phase 2b trial investigating two dose levels of bavituximab plus docetaxel...
Lubiprostone drug found to reduce abdominal pain in IBS-C patients
Sucampo Pharmaceuticals has announced the pooled data from post-hoc analyses of the two pivotal Phase 3 studies of Amitiza (lubiprostone), used for the treatment of irritable bowel syndrome...
Tokai announces positive galeterone data from Phase 1 study
Tokai Pharmaceuticals has reported additional data from a Phase 1 safety and proof-of-concept study investigating galeterone (TOK-001), in patients with castration-resistant prostate cancer...
Elevation reveals positive results from EP-101 study
Elevation Pharmaceuticals has announced positive results from a Phase 2b study of EP-101 in patients with chronic obstructive pulmonary disease (COPD), a progressive disease comprising...
Nucynta ER tablets show efficacy in pain management
Janssen Pharmaceuticals' Nucynta (tapentadol) extended-release (ER) tablets have been found effective in providing pain management among adults with chronic moderate to severe, painful...
Achaogen plazomicin drug meets Phase 2 study endpoints
Achaogen's plazomicin (ACHN-490) drug has met all the objectives in the multinational Phase 2 study conducted in adults with complicated urinary tract infections (cUTI) and acute...
Tivozanib drug shows superior PFS over sorafenib in Phase 3 study
Aveo Oncology and Astellas Pharma have announced positive findings from the Tivozanib Versus Sorafenib in 1st line Advanced RCC (TIVO-1) study of its investigational agent...
Galectin begins Phase 1/2 study of GM-CT-01 combination therapy
Galectin Therapeutics has dosed the first patient in a Phase 1/2 trial demonstrating the safety and efficacy of its carbohydrate-based galectin inhibitor compound, GM-CT-01, in combination with...
Scil Proteins, Ono Pharmaceutical enter into drug discovery alliance
Germany-based biotech company, Scil Proteins, has entered into a joint collaboration agreement with Japan's Ono Pharmaceutical for the discovery and development of new Affilin therapeutics to...
Diltiazem hydrochloride cream shows improvement over placebo in study
Ventrus Biosciences has reported positive data from a Phase 3 study treating patients suffering from anal fissures with its diltiazem hydrochloride cream (VEN...
Press Releases
Meet Biovian at the Biotech Outsourcing Strategies Conference
Meet Biovian at the Biotech Outsourcing Strategies cmc2012 (BOS cmc) on 14 June 2012 at the Sohuset Conference Center, Denmark. Biovian's director of business development and projects, Dr...
Meet Biovian at Lyckad Läkemedelsutveckling in Stockholm
Meet Biovian at 'Lyckad Läkemedelsutveckling' seminar on 31 May 2012 at Hotel Grand, Stockholm, Sweden. Biovian's Director of Business Development and Projects, Dr Knut Ringbom will be...
Fujifilm Diosynth Biotechnologies Invests in New Equipment and Labs at UK Facility
Fujifilm Diosynth Biotechnologies has completed the first phase of a £3m ($4.5m) investment in new equipment and laboratories at its Billingham, UK...
Tissue Solutions Achieves Certification to ISO 9001
Tissue Solutions is pleased to announce that it has been awarded ISO 9001:2008 BSI...
GlycoMar Releases New White Paper: Oligosaccharides in Drug Discovery
Glycobiology is concerned with the study of structure, biosynthesis, and function of saccharides (sugar chains), which may exist purely or conjugated to other biological molecules to...
Joint UK-Norwegian Support to Aid Development of Industrial Biotechnology Sector
The British and Norwegian governments are to work together to support nine new research and development projects that will create innovative processes to generate high‐value chemicals...
Priorclave's Compact C40 Vacuum Autoclave Now Available with Stand-Off Legs
Priorclave's Compact C40 vacuum autoclave is the first priorclave to become available with stand-off legs, providing easy access beneath the steam steriliser for cleaning and disinfection...
Priorclave Autoclave is a Success at London Vet Show
During the recent London Vet Show the autoclave supplied by Priorclave and featured on the Southwest Medical stand surprised visitors with its compact outward physical appearance and the...
York University Awards Autoclave Contract to Priorclave
York University will soon be taking delivery of a number of priorclaves for use in the biology department's teaching laboratories and associated central wash-up and sterilising...
Tissue Solutions, OracleBio and Histologix Join Forces to Provide Tissue to Data Biomarker Solutions
A new partnership provides tissue to data biomarker solutions. 'Our expertise provides your solutions' is the new motto being used as part of a unique and exciting partnership between...
